Personalized Stem Cells Clinical Trial Update

Personalized Stem Cells (PSC) treated the first patients in an FDA-approved clinical trial for stem cell treatment of knee osteoarthritis (OA). The company received FDA approval for the trial earlier this year.

The multi-site trial will treat up to 125 patients throughout the U.S. Additional clinical trial sites will be added in the coming...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us